GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tenon Medical Inc (NAS:TNON) » Definitions » Return-on-Tangible-Equity

Tenon Medical (Tenon Medical) Return-on-Tangible-Equity : -649.89% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Tenon Medical Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Tenon Medical's annualized net income for the quarter that ended in Mar. 2024 was $-14.30 Mil. Tenon Medical's average shareholder tangible equity for the quarter that ended in Mar. 2024 was $2.20 Mil. Therefore, Tenon Medical's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was -649.89%.

The historical rank and industry rank for Tenon Medical's Return-on-Tangible-Equity or its related term are showing as below:

TNON' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -695.76   Med: -443.27   Max: -443.27
Current: -695.76

During the past 4 years, Tenon Medical's highest Return-on-Tangible-Equity was -443.27%. The lowest was -695.76%. And the median was -443.27%.

TNON's Return-on-Tangible-Equity is ranked worse than
96.97% of 760 companies
in the Medical Devices & Instruments industry
Industry Median: 1.395 vs TNON: -695.76

Tenon Medical Return-on-Tangible-Equity Historical Data

The historical data trend for Tenon Medical's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenon Medical Return-on-Tangible-Equity Chart

Tenon Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
- - - -443.27

Tenon Medical Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -442.81 -1,015.10 -779.42 -760.91 -649.89

Competitive Comparison of Tenon Medical's Return-on-Tangible-Equity

For the Medical Devices subindustry, Tenon Medical's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tenon Medical's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tenon Medical's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Tenon Medical's Return-on-Tangible-Equity falls into.



Tenon Medical Return-on-Tangible-Equity Calculation

Tenon Medical's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-15.581/( (6.252+0.778 )/ 2 )
=-15.581/3.515
=-443.27 %

Tenon Medical's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=-14.304/( (0.778+3.624)/ 2 )
=-14.304/2.201
=-649.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Tenon Medical  (NAS:TNON) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Tenon Medical Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Tenon Medical's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Tenon Medical (Tenon Medical) Business Description

Traded in Other Exchanges
N/A
Address
104 Cooper Court, Los Gatos, CA, USA, 95032
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
Executives
Van Dick Steven M officer: Chief Financial Officer HANSEN MEDICAL, INC., 380 N BERNARDO AVENUE, MOUNTAIN VIEW CA 94043
Richard Ginn director, officer: Chief Technology Officer 104 COOPER COURT, LOS GATOS CA 95032
Steven M Foster director, officer: CEO and President 104 COOPER COURT, LOS GATOS CA 95032
Stephen Hochschuler director C/O TENON MEDICAL, INC., 104 COOPER COURT, LOS GATOS CA 95032
Frank M Fischer director 9701 JERONIMO, IRVINE CA 92618
Richard M Ferrari director 2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Ivan Howard director 104 COOPER COURT, LOS GATOS CA 95032
Robert K Weigle director 104 COOPER COURT, LOS GATOS CA 95032
Ventures Ag Zuhlke 10 percent owner ZURCHERSTRASSE 39J, SCHLIEREN V8 8952